Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhixiao Sanjie Fang is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for the treatment of diabetic nephropathy (DN) and diabetic kidney disease. The formula is designed to address the TCM pathological state of "Qi deficiency and blood stasis," which is commonly associated with chronic microvascular complications in diabetes. It typically comprises botanical and animal-derived ingredients, including *Astragalus membranaceus* (Huangqi), *Rheum palmatum* (Dahuang), and *Hirudo* (Shuizhi). Research indicates that Zhixiao Sanjie Fang may exert therapeutic effects by reducing urinary albumin excretion, improving renal function, and inhibiting renal fibrosis. Its mechanism of action involves the modulation of the TGF-β1/Smad signaling pathway, the reduction of pro-inflammatory cytokines, and the protection of podocytes from oxidative stress and apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhixiao Sanjie Fang.